Peterson McVicar acts for Leede Jones Gable Inc. in a proposed Private Placement with Acasti Pharma Inc.
On February 1, 2017 Leede Jones Gable Inc. entered into a finder’s agreement with Acasti Pharma Inc. (“Acasti”) in connection with a proposed private placement of $2 million aggregate principal amount of unsecured convertible debentures and warrants to acquire Class A shares of Acasti, with arm’s length investors (collectively, the “Private Placement”).
In part, the Private Placement is intended to provide a comprehensive financing package to fund Acasti’s operations until December 31, 2017, through the completion of the manufacturing scale-up and planning for the Phase 3 clinical trial for the continued development of CaPre®.
Leede Jones Gable is one of Canada’s leading independent investment dealers, providing a full range of investment products and services to clients all across Canada.
Peterson McVicar Acts for Red Cloud Securities Inc. in Brokered Private Placement with Reyna Silver Corp. for up to C$3.0 Million
Peterson McVicar Acts for Galway Metals in Upsizing of $8 Million Bought Deal Private Placement Financing to $10 Million